Bioharvest Sciences, Inc. (TSE:BHSC) has released an update.
Bioharvest Sciences Inc. is poised for growth in 2024, having reported an 85% increase in revenue to $4.5 million and improved margins in the fourth quarter of 2023. The biotech firm, which specializes in plant-based molecule production without growing the plants, will discuss its financial successes, recent facility expansion, and strategies for Nasdaq listing in an upcoming corporate update call. Investors and shareholders are invited to join the call, which includes a live Q+A session, to gain insights into the company’s future plans and operational achievements.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
